Zoetis Inc. (ZTS) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Zoetis Inc. (ZTS) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

ZTS

Market Closed

Zoetis Inc.

NYSEHealthcare Drug Manufacturers - General

13.80K employees

CEO: Kristin C. Peck

Founded: 2013

$78.71

+$0.00(+NaN%)

Market Cap

33.00B

Beta

0.74

52W Range

N/A

Dividend Yield

2.62%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

70.5%

4.3%

CAGR: 5.9%

Profit after direct costs

Operating Margin

38.0%

6.0%

CAGR: 6.4%

Core business profitability

Net Margin

28.2%

7.5%

CAGR: 7.0%

Bottom line profitability

Revenue Growth

2.3%

YoY

CAGR: 5.0%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how ZTS allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

70.5%

$6.67B

Operating Margin

38.0%

$3.60B

Net Margin

28.2%

$2.67B

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	7.78B	8.08B	8.54B	9.26B	9.47B	2.3%
Cost of Revenue	(2.46B)	(2.60B)	(2.71B)	(2.86B)	(2.79B)	-2.3%
Gross Profit	5.31B	5.48B	5.83B	6.40B	6.67B	4.3%
Operating Expenses
Research & Development	(508.00M)	(539.00M)	(614.00M)	(686.00M)	(698.00M)	1.7%
Selling, General & Administrative	(2.00B)	(2.01B)	(2.15B)	(2.32B)	(2.38B)	2.6%
Depreciation & Amortization	(448.00M)	(465.00M)	(491.00M)	(497.00M)	(487.00M)	-2.0%
Operating Income (EBIT)	2.80B	2.93B	3.07B	3.39B	3.60B	6.0%
Non-Operating Items
Interest Income	6.00M	50.00M	105.00M	106.00M	93.00M	-12.3%
Interest Expense	(236.00M)	(237.00M)	(258.00M)	(242.00M)	(243.00M)	0.4%
Other Income/Expenses (Net)	-315.00M	-272.00M	-133.00M	-259.00M	-237.00M	-8.5%
Income Before Tax	2.49B	2.66B	2.94B	3.13B	3.36B	7.2%
Income Tax Expense	(454.00M)	(545.00M)	(596.00M)	(637.00M)	(687.00M)	7.8%
Net Income	2.04B	2.11B	2.34B	2.49B	2.67B	7.5%
Per Share Metrics
Earnings Per Share (Basic)	$4	$5	$5	$5	$6	10.2%
Weighted Avg Shares Outstanding	474.35M	468.89M	461.17M	454.20M	443.44M	-2.4%
Weighted Avg Shares Outstanding (Diluted)	476.72M	470.38M	462.27M	454.85M	443.83M	-2.4%
EBITDA	3.17B	3.36B	3.69B	3.87B	4.07B	5.1%

Explore ZTS

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ZTS in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →